Home / Biotechnology / Metabolomics Market By Product And Services (Metabolomic Instruments, Metabolomics Bioinformatics Tools And Services), By Application (Biomarker Discovery, Drug Discovery, Functional Genomics, Personalized Medicine, Toxicology Testing, Nutrigenomics), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Metabolomics Market By Product And Services (Metabolomic Instruments, Metabolomics Bioinformatics Tools And Services), By Application (Biomarker Discovery, Drug Discovery, Functional Genomics, Personalized Medicine, Toxicology Testing, Nutrigenomics), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Published: Apr 2017 | Report Code: 58420-04-17

Metabolomics is a novel, emerging and dynamic field that studies metabolites, a distinctive chemical fingerprints produced during cellular process. Thus it identifies and quantifies metabolites further with the help of analytical technologies and application of bioinformatics extract information and analyze the same. Metabolomics though currently at nascent stage, will be widely used in biopharma and biotech industry as biomarker drug development and information. Being non-invasive in nature and closely linked to phenotype, it is an ideal tool used in agricultural industries, pharmaceutical and preventive healthcare. Rise in the number of clinical trials, awareness about nutritional products, toxicological testing data, rapid growth of metabolomics data analysis software and solutions is expected to propel the growth of this market.

The report titled “Metabolomics market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall metabolomics market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of product and services, application, indication and different geographies. The product and services type segment studied for analyzing the overall global metabolomics market is majorly segmented into metabolomics instruments and metabolomics bioinformatics tools and services. Metabolomics instruments is sub-segmented into separation tools and detection tools. Separation tools include high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography and capillary electrophoresis. Detection tools comprise mass spectrometry, nuclear magnetic resonance spectroscopy and surface-based mass analysis. Metabolomics bioinformatics tools and services category is sub-segmented into bioinformatics tools & databases, and bioinformatics services. The global metabolomics market is segmented by application type into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine and others. Based on indications, this market is categorized into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism and others.

Geographically, the global metabolomics market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global metabolomics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global metabolomics market. This report concludes with company profiles section that highlights major information about the key players engaged in global metabolomics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Metabolomics Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Metabolomics Portraiture
2.2 Global Metabolomics Share, by Product and Service, 2016 (US $ Mn)
2.3 Global Metabolomics, by Type of Application, 2016 (US$ Mn)
2.4 Global Metabolomics, by Type of Indication, 2016 (US$ Mn)
2.5 Global Metabolomics, by Geography, 2016 (Value %)

Chapter 3 Global Metabolomics Analysis
3.1 Global Metabolomics Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition, 2016
3.4 Market Positioning Analysis of Key Players: Metabolomics Market, 2016

Chapter 4 Global Metabolomics Analysis, by Product and Services, 2015-2025 (US$)
4.1 Introduction
4.2 Metabolomic Instruments
4.2.1 Separation Tools
4.2.1.1 Gas Chromatography
4.2.1.2 Ultra-Performance Liquid Chromatography
4.2.1.3 Capillary Electrophoresis
4.2.2 Detection Tools
4.2.2.1 Mass Spectrometry
4.2.2.1 Nuclear Magnetic Resonance Spectroscopy
4.2.2.1 Surface-Based Mass Analysis
4.3 Metabolomics Bioinformatics Tools and Services
4.3.1 Bioinformatics Tools & Databases
4.3.2 Bioinformatics Services

Chapter 5 Metabolomics Analysis, by Application, 2015-2025 (US$)
5.1 Introduction
5.2 Biomarker Discovery
5.3 Drug Discovery
5.4 Functional Genomics
5.5 Personalized Medicine
5.6 Toxicology Testing
5.7 Nutrigenomics
5.8 Others

Chapter 6 Metabolomics Analysis, by Indication, 2015-2025 (US$)
6.1 Introduction
6.2 Cancer
6.3 Cardiovascular Disorders
6.4 Neurological Disorders
6.5 Inborn Errors of Metabolism
6.6 Others

Chapter 7 Global Metabolomics, By Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.3 Europe (U.K., Germany & Rest of Europe)
7.4 Asia Pacific (China, Japan, and Rest of APAC)
7.5 Latin America (Brazil, Mexico and Rest of LATAM)
7.6 Middle East and Africa

Chapter 8 Company Profiles
8.1 Agilent Technologies, Inc.
8.2 Acureomics AB
8.3 Amatsi Group
8.4 Bayer, Inc.
8.5 Berg LLC
8.6 Biocrates Life Sciences AG
8.7 Bio-Rad Laboratories, Inc.
8.8 Bruker Corporation
8.9 Chenomx,Inc
8.10 Danher Corporation
8.11 Human Metabolome Technologies, Inc.
8.12 HepatoChem, Inc.
8.13 IROA Technologies
8.14 Leco Corporation
8.15 Metabolon, Inc.
8.16 Max Planck Society
8.17 Metabolomic Discoveries GmbH
8.18 Metabolomx
8.19 Metabometrix Ltd.
8.20 Metanomics GmbH
8.21 Phenomenome Discoveries, Inc.
8.22 SCIEX
8.23 Shimadzu Corporation
8.24 SiDMAP
8.25 Stemina Biomarker Discovery, Inc
8.26 Thermo Fisher Scientific, Inc.
8.27 Waters Corporation
8.28 Xceleron, Inc.
8.29 Other Notable Players

Note:

  • Profiles of specific players, if required, shall be added to the report upon request

List Of Tables :

TABLE 1 Global Metabolomics, By Product and Services, 2015-2025 (US$ Mn)
TABLE 2 Global Metabolomics Instruments Market, 2015-2025 (US$ Mn)
TABLE 3 Global Metabolomics Separation Tools Market, 2015-2025 (US$ Mn)
TABLE 4 Global Metabolomics Detection Tools Market, 2015-2025 (US$ Mn)
TABLE 5 Metabolomics, by Application Type , 2015-2025 (US$ Mn)
TABLE 6 Metabolomics, by Application Type , 2015-2025 (US$ Mn)
TABLE 7 Global Metabolomics, by Geography, 2015 – 2025 (US$ Mn)
TABLE 8 North America Metabolomics, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Metabolomics, by Country, 2015 – 2025 (USD Mn)
TABLE 10 Asia-Pacific Metabolomics, by Country, 2015 – 2025 (USD Mn)
TABLE 11 Agilent Technologies, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 12 Acureomics AB: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 13 Amatsi Group: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 14 Bayer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
TABLE 15 Berg LLC: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 Biocrates Life Sciences AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Bruker Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 Chenomx,Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 20 Danher Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 21 Human Metabolome Technologies, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 22 HepatoChem, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 23 IROA Technologies: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 24 Leco Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 25 Metabolon, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 26 Max Planck Society: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 27 Metabolomic Discoveries GmbH: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 28 Metabolomx: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 29 H Metabometrix Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 30 Metanomics GmbH: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 31 Phenomenome Discoveries, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 32 SCIEX: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 33 Shimadzu Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 34 SiDMAP: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 35 Stemina Biomarker Discovery, Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 36 Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 37 Waters Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 38 Xceleron, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)

List Of Figures :

FIG. 1 Global Metabolomics: Research Methodology
FIG. 2 Global Metabolomics Share, by Product and Service, 2016 (US$ Mn)
FIG. 3 Global Metabolomics, by Type of Application, 2016 (US$ Mn)
FIG. 4 Global Metabolomics, by Type of Indication, 2016 (US$ Mn)
FIG. 5 Global Metabolomics, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition: Global Metabolomics, by Geography
FIG. 7 Competitive Analysis: Key Players in Global Metabolomics
FIG. 8 Global Metabolomics Gas Chromatography Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Metabolomics Ultra-Performance Liquid Chromatography Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Metabolomics Capillary Electrophoresis Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Metabolomics Mass Spectrometry Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Metabolomics Nuclear Magnetic Resonance Spectroscopy Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Metabolomics Surface-Based Mass Analysis Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Metabolomics Bioinformatics Tools & Databases Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Metabolomics Bioinformatics Services Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Biomarker Discovery Market , 2015 – 2025 (US$ Mn)
FIG. 17 Global Drug Discovery Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Functional Genomics Market, 2014 – 2024 (US$ Mn)
FIG. 19 Global Personalized Medicine Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Toxicology Testing Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Nutrigenomics Market, 2015 – 2025 (US$ Mn)
FIG. 22 Global Other Application Market, 2015 – 2025 (US$ Mn)
FIG. 23 Global Metabolomics Market, By Cancer Application , 2015 – 2025 (US$ Mn)
FIG. 24 Global Metabolomics Market, By Cardiovascular Disorders Application, 2015 – 2025 (US$ Mn)
FIG. 25 Global Metabolomics Market, By Neurological Disorder Application Market, 2015 – 2025 (US$ Mn)
FIG. 26 Global Metabolomics Market, By Inborn Errors of Metabolism Application, 2015 – 2025 (US$ Mn)
FIG. 27 Global Metabolomics Market, By Other Application Market, 2015 – 2025 (US$ Mn)
FIG. 28 Latin America Metabolomics, 2015 – 2025 (US$ Mn)
FIG. 29 Middle East & Africa Metabolomics, 2015 – 2025 (US$ Mn)

Based on the type of product and services, the global metabolomics market is segmented as follows:

  • Metabolomics Instruments
    • Separation Tools
      • High-Performance Liquid Chromatography
      • Gas Chromatography
      • Ultra-Performance Liquid Chromatography
      • Capillary Electrophoresis
    • Detection Tools
      • Mass Spectrometry
      • Nuclear Magnetic Resonance Spectroscopy
      • Surface-Based Mass Analysis
  • Metabolomics Bioinformatics Tools and Services
    • Bioinformatics Tools & Databases
    • Bioinformatics Services

Metabolomics instrument occupies the largest share of global metabolomics market. Metabolomics bioinformatics tools and services is fast growing segment during the forecast period. With further technological developments, bioinformatics tools have enhanced the untargeted metabolomics workflow, enabling researchers to identify metabolite from LC/MS data and assign their biological roles with respect to chemical pathways. In separation tools segments, High-performance liquid chromatography dominates the market. While ultra-performance liquid chromatography provides high efficiency and high resolution chromatographic separation, with reduction in analysis time, hence anticipated to be fast growing market in future. Detection tool segment, mass spectrometry occupies the maximum share, with nuclear magnetic resonance spectroscopy showing fast adaptability and bright future market growth.

Metabolomics Market

Based on the type of application, the global metabolomics market is segmented as follows:

  • Biomarker Discovery
  • Drug Discovery
  • Functional Genomics
  • Personalized Medicine
  • Toxicology Testing
  • Nutrigenomics
  • Others

Biomarker discovery occupies the largest share of the global metabolomics market. Metabolomics techniques aid in discovering the potential biomarkers and providing insight into pathogeneses of numerous human diseases. With advancement in analytical technology, it possible to quantify the biomarkers from small amount of specimens using minimally invasive or non-invasive procedure, to facilitate high throughput analysis for real time application in clinical setting. Drug discovery is next followed up market for metabolomics. Metabolomics helps in diagnosing the disease by understanding the biochemical pathway, thus further aiding in drug identification, designing and customization according therapeutic needs. Personalized medicine is anticipated to be the fastest growing segment during the forecast period with biotech and pharma companies investing heavily in it research and development.

Metabolomics Market

Based on the type of indication, the global metabolomics market is segmented as follows:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Cancer dominates the global metabolomics market by indication segmentation. Cancer study through metabolomics helps in revealing new biomarkers for cancer which would help in future diagnosis, prognosis and therapy. Cardiovascular chronic disease is the greatest public health burden globally. Thus use of metabolomic profiling would help to identify new biomarkers and mechanisms of CVD risk. Current clinical diagnosis of neurological diseases such as Parkinson’s and Alzheimer diseases on basis of clinical criteria is unsatisfactory, so emerging metabolomics techniques help in discovering in now biomarker and biochemical pathway for improving the  future diagnosis and determination of prognosis therapy.

Metabolomics Market

For the purpose of this study, the global metabolomics market is geographically categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Metabolomics Market

North America dominates the global metabolomics market followed by Europe. The key drivers are surge in research and development funding by government and private players for metabolomics studies, rising demand for personalized medicine and toxicology testing, easy accessibility of technologically advanced products and its high adoption rate, presence of various metabolomics manufactures. Growing demand for the personalized medicine, large presence of the analytical equipment manufacturers in Europe contribute to the growth of metabolomics market. Asia Pacific has significant growth opportunity for the metabolomics market due to presence of number of pharmaceutical and biotechnology companies and its initiatives in research and development, improving health care infrastructure, emerging economies such as China, Japan, India and Singapore.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients